Your browser doesn't support javascript.
loading
Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer.
Han, Guohu; Sun, Changchun; Cui, Lihua; Huang, Yufeng; Yu, Lijiang; Liu, Shenzha; Tao, Min.
Afiliación
  • Han G; Department of Oncology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu, China.
  • Sun C; Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
  • Cui L; Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
  • Huang Y; Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
  • Yu L; Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
  • Liu S; Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
  • Tao M; Department of Oncology, Jingjiang People's Hospital, The Seventh Affiliated Hospital of Yangzhou University, Jingjiang, Jiangsu, China.
Pathol Oncol Res ; 29: 1611114, 2023.
Article en En | MEDLINE | ID: mdl-37465317

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Hipertermia Inducida / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pathol Oncol Res Asunto de la revista: NEOPLASIAS / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Hipertermia Inducida / Antineoplásicos Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Pathol Oncol Res Asunto de la revista: NEOPLASIAS / PATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza